Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

NSE/INFLUX stock hub

NSE/INFLUX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/INFLUXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.4B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/INFLUX

In the news

Latest news · NSE/INFLUX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E30.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC32.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/INFLUX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

142

Groups with data

Currency

INR

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	163
Employees Change	-2%
Employees Change Percent	-1.21
Enterprise value	INR 6.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-05-10
Market cap	INR 6.4B
Price	INR 278
Price currency	INR
Rev Per Employee	7,580,276.07x
Sic	2833
Symbol	nse/INFLUX
Website	https://influxhealthtech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.76%
EV Earnings	34.2x
EV/EBIT	26.34x
EV/EBITDA	23.04x
EV/Sales	4.91x
P/B ratio	7.14x
P/E ratio	30.54x
P/S ratio	5.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.66%
EBITDA Margin	21.33%
Gross margin	41.92%
Gross Profit	INR 517.9M
Gross Profit Growth	123.31%
Net Income	INR 177.6M
Net Income Growth	146.73%
Pretax Margin	18.82%
Profit Margin	14.37%
Profit Per Employee	INR 1.1M
ROCE	25.54
ROIC	32.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	130
Revenue Growth	62.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	INR 1.1B
Cash	INR 365.6M
Current Assets	INR 825.6M
Current Liabilities	INR 232.9M
Equity	INR 902.3M
Liabilities	INR 233.1M
Long Term Assets	INR 309.8M
Long Term Liabilities	INR 173,000
Net Cash	INR 365.6M
Net Cash By Market Cap	INR 5.68
Net Debt EBITDA	INR -1.39
Net Debt Equity	INR -0.41
Tangible Book Value	INR 902M
Tangible Book Value Per Share	INR 43.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.54
Net Working Capital	INR 227M
Quick ratio	3.03
Working Capital	INR 592.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	203.6
50-day SMA	231.4
50-day SMA vs 200-day SMA	50over200
All Time High	290
All Time High Change	-4.1%
All Time High Date	2026-04-21
All Time Low	120
All Time Low Change	131.75%
All Time Low Date	2025-06-26
ATR	15.37
Beta1y	-0.37
Ch YTD	23
High	283
High52	290
High52 Date	2026-04-21
High52ch	-4.1%
Low	273
Low52	120
Low52 Date	2025-06-26
Low52ch	131.75%
Ma50ch	20.21%
Price vs 200-day SMA	36.6%
RSI	65.05
RSI Monthly	0
RSI Weekly	71.79
Sharpe ratio	1.87x
Sortino ratio	3.22
Total Return	-7.38%
Tr YTD	23
Tr1m	27.04%
Tr1w	-0.82%
Tr3m	23.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 230.5M
Operating Income Growth	135.6
Operating margin	18.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,125,810%
Shares Insiders	73.54%
Shares Out	23,150,400
Shares Qo Q	0%
Shares Yo Y	7.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	49,650x
Bv Per Share	43.35
Ch1m	27.04
Ch1w	-0.82
Ch3m	23.52
Ch6m	44.17
Change	-1.61%
Change From Open	-0.68
Close	282.7
Days Gap	-0.94
Depreciation Amortization	33,079,000
Dollar Volume	7,174,980
Earnings Date	2026-06-11
EBIT	INR 230.5M
EBITDA	INR 263.6M
EPS	INR 9.11
F Score	3
Fiscal Year End	March
Founded	2,003
Graham Number	94.24278
Graham Upside	-66.11
Income Tax	INR 54.9M
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-09-30
Ma150	215.2
Ma150ch	29.24%
Ma20	257.4
Ma20ch	8.04%
Next Earnings Date	2026-06-11
Open	280
Position In Range	51.26
Ppne	247,358,000
Price Date	2026-05-08
Price EBITDA	INR 24.42
Ptbv Ratio	7.14
Relative Volume	0.52x
Revenue	1,235,585,000x
Tax By Revenue	4.45x
Tax Rate	23.63%
Tr6m	44.17%
Volume	25,800
Z Score	12.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/INFLUX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/INFLUX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+73.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.4%

Negative means the company is buying back shares.

Technical

NSE/INFLUX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.0

Neutral momentum band

Price vs 200-day MA

+36.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/INFLUX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/INFLUX stock rating?

nse/INFLUX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/INFLUX analysis?

The full report lives at /stocks/nse/INFLUX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/INFLUX?

The latest report frames nse/INFLUX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/INFLUX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.